| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Net (loss) income before taxes | -103,433 | - | - | 1,001,035 |
| Income tax expense | 0 | - | - | 53,120 |
| Net (loss) income | -103,433 | -112,020 | -89,289 | 947,915 |
| Net (loss) income per share - basic (in usd per share) | -1.78 | -1.93 | -1.55 | 16.65 |
| Net (loss) income per share - diluted (in usd per share) | -1.78 | -1.93 | -1.55 | 16.22 |
| Weighted-average number of common shares used in computing net (loss) income per share basic (in shares) | 58,139,277 | 57,932,576 | 57,459,195 | 56,939,403 |
| Weighted-average number of common shares used in computing net (loss) income per share diluted (in shares) | 58,139,277 | 57,932,576 | 57,459,195 | 58,432,796 |
AGIOS PHARMACEUTICALS, INC. (AGIO)
AGIOS PHARMACEUTICALS, INC. (AGIO)